In this issue:
- Cannabidiol vs. placebo for fibromyalgia
- Disease activity, function and HR-QoL in axSpA
- Physical strain and joint inflammation in ACPA-positive RA
- Longevity of modern hip replacements
- The Southend GCA Probability Score in NZ
- NSAIDs and spinal progression in axSpA
- CORAL: a risk score for infection with prolonged high-dose glucocorticoids
- GCA diagnosis/management in Australia
- Switch to an IL-17A inhibitor vs. a second TNF inhibitor in PsA/axSpA
- Blinatumomab/teclistamab in treatment-refractory ASyS/SSc
Please login below to download this issue (PDF)